Tulane University

Running trials

• Not yet recruiting

  Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy

  NCT07795593· Phase 4· Source

• Recruiting

  Combatting HIV Or Other STIs Early (CHOOSE)

  NCT07510048· Source

• Recruiting

  Detection of Atrial Fibrillation Using PPG From Smartphone Cameras

  NCT07779213· Source

• Recruiting

  Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

  NCT06837181· Source

• Recruiting

  Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

  NCT06750731· Source

• Active, not recruiting

  A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD

  NCT06713239· Source

• Recruiting

  A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

  NCT06544499· Phase 3· Source

• Recruiting

  Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)

  NCT06472206· Source

• Active, not recruiting

  A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

  NCT06095128· Phase 4· Source

• Active, not recruiting

  A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

  NCT06045754· Phase 4· Source

• Recruiting

  Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)

  NCT06133322· Source

• Active, not recruiting

  Lupus Education Alliance Program

  NCT05243875· Source

• Active, not recruiting

  Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health

  NCT06065098· Source

• Active, not recruiting

  Real World Registry for Use of the Ion Endoluminal System

  NCT06004440· Source

• Active, not recruiting

  Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF

  NCT05639556· Source

• Recruiting

  Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention

  NCT05723653· Source

• Active, not recruiting

  Emicizumab in Patients With Acquired Hemophilia A

  NCT05345197· Phase 2· Source

• Active, not recruiting

  Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)

  NCT05382208· Phase 2· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer

  NCT05353257· Phase 3· Source

• Active, not recruiting

  Pyrocarbon Clinical Follow-up Study

  NCT05049993· Source

• Active, not recruiting

  Prospective Study of Pregnancy in Women With Cystic Fibrosis

  NCT04828382· Source

• Active, not recruiting

  A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

  NCT04680052· Phase 3· Source

• Active, not recruiting

  The Allergen Reduction and Child Health Study (ARCHS)

  NCT04331353· Source

• Active, not recruiting

  Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis

  NCT04440189· Phase 3· Source

• Active, not recruiting

  Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

  NCT04228978· Source

• Active, not recruiting

  Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

  NCT03976843· Phase 2· Source

• Active, not recruiting

  Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control in Minimize Cognitive Decline

  NCT04797403· Source

• Active, not recruiting

  Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A

  NCT03932201· Source

• Recruiting

  Stroke Thrombectomy and Aneurysm Registry

  NCT04994756· Source

• Recruiting

  International Registry for Men With Advanced Prostate Cancer (IRONMAN)

  NCT03151629· Source

• Active, not recruiting

  A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

  NCT02954094· Source

• Recruiting

  Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  NCT01915511· Source

• Active, not recruiting

  Bogalusa Heart Study

  NCT00005129· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• HIV3 recruiting
• Atrial fibrillation1 recruiting
• Brain aneurysm1 recruiting
• Crohn's disease1 recruiting
• Cystic fibrosis1 recruiting
• High blood pressure1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• Immune thrombocytopenia (ITP)1 recruiting
• Stroke1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

  NCT06016088· Phase 1/2· Source

• Completed

  Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis

  NCT05199337· Phase 1/2· Source

• Completed

  Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)

  NCT05172024· Source

• Completed

  A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment

  NCT05014412· Phase 2· Source

• Completed

  Study to Learn More About the Physical Activity Level of Patients Suffering From Hemophilia A Treated With Damoctocog Alfa Pegol (LIFE ACTIVE Study)

  NCT04091386· Source

• Terminated

  To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)

  NCT04551053· Phase 3· Source

• Terminated

  To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

  NCT04551066· Phase 3· Source

• Completed

  Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial

  NCT04300920· Phase 3· Source

• Terminated

  Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage

  NCT03926624· Phase 3· Source

• Completed

  CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

  NCT03934840· Phase 2· Source

• Completed

  Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

  NCT03529045· Source

• Completed

  An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer

  NCT03338790· Phase 2· Source

• Completed

  Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection

  NCT03205696· Source

• Completed

  Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer

  NCT03098836· Phase 2· Source

• Completed

  Improve PAD PERformance With METformin

  NCT03054519· Phase 3· Source

• Completed

  Medacta GMK Sphere® Multicenter Post-Market Outcomes Study

  NCT02501733· Source